Bioptik Technology (4161) — Free Cash Flow Generation Index
Bioptik Technology (4161) has a Free Cash Flow Generation Index of 0.91x as of December 2025. Free cash flow of NT$48.27 Million represents 1% of operating cash flow (NT$53.21 Million). See 4161 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Bioptik Technology Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Bioptik Technology across 8 annual periods. Explore debt repayment capacity of Bioptik Technology to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Bioptik Technology (2017–2025)
Year-by-year Free Cash Flow Generation Index for Bioptik Technology. For the full company profile including market capitalisation, see market value of Bioptik Technology.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.62x | NT$37.19 Million | NT$59.99 Million | NT$22.80 Million | ▼ -31.3% |
| 2024 | 0.90x | NT$143.32 Million | NT$158.82 Million | NT$15.51 Million | ▲ +6.3% |
| 2023 | 0.85x | NT$174.91 Million | NT$205.95 Million | NT$31.04 Million | ▲ +23.1% |
| 2022 | 0.69x | NT$37.98 Million | NT$55.06 Million | NT$17.08 Million | ▲ +168.6% |
| 2020 | -1.01x | NT$-6.61 Million | NT$6.57 Million | NT$13.18 Million | ▼ -429.7% |
| 2019 | 0.30x | NT$12.51 Million | NT$41.03 Million | NT$27.42 Million | ▲ +226.1% |
| 2018 | -0.24x | NT$-10.11 Million | NT$41.83 Million | NT$50.96 Million | ▲ +94.9% |
| 2017 | -4.72x | NT$-52.04 Million | NT$11.02 Million | NT$62.72 Million | — |